THCT THC Therapeutics Inc (CE)

Cannabis stocks have dipped with the broader market making now an ideal time to start researching some gems you may have missed.

Las Vegas, NV -- June 3, 2019 -- InvestorsHub NewsWire -- via Regal Consulting

That’s why we’re highlighting THC Therapeutics, Inc. (THCT).  THCT also recently differentiated itself when it announced the appointment of Enzo Villani to the company’s Board of Directors.  Mr. Villani has raised over $500 million in funding from strategic investors, private equity, venture capital, family offices and the public markets during his over twenty-year career.

THCT’s dHydronator® can reduce moisture content of cannabis to 10% in only 10-14 hours.  This is the same reason Aurora just signed $10M deal with EnWave.  THCT received patent protection on 20 claims from the US patent office and will be using their patented designs to carve out their piece of the legal cannabis market expected to reach $146.4 billion by 2025.

Today we are highlighting: THC Therapeutics, Inc. (THCT), Cronos Group Inc. (CRON), MedMen Enterprises Inc. (MMNFF), The Green Organic Dutchman Holdings Ltd. (TGODF), and MariMed Inc. (MRMD).

THC Therapeutics, Inc. (THCT) (Market Cap: $99.839M; Share Price: $7.25) has developed a sanitizing herb dryer, The dHydronator®.  Their laboratory-proven product is specifically designed for drying and sanitizing freshly harvested cannabis and herbs.  THCT’s product has been tested by two independent laboratories.  The testing covered over 6 strains and 9 independent tests to confirm the findings.  Over the 9 tests and 6 strains, there was a 4% average increase of THC-A*.

The US patent office has accepted ALL 20 claims for the dHydronator®.  The company has received full patent protection for the dHydronator®; this is big.  Start your research today on THCT.

________

Cronos Group Inc. (CRON) (Market Cap: $4.781B; Share Price: $14.08) announced a multi-year supply agreement with MediPharm Labs Corp.  MediPharm Labs will supply Cronos with private label cannabis concentrate over an 18-to-24-month period.  This agreement will provide Cronos Group with specialized extraction capabilities and expertise to serve growing consumer and market demand.  Cronos Group is a global cannabinoid company with international production and distribution focused on advancing cannabis research, technology and product development.

________

MedMen Enterprises Inc. (MMNFF) (Market Cap: $368.585M; Share Price: $2.19) released news that they have been advanced an additional US $80M in gross proceeds following the secured $250M convertible credit facility with Gotham Green Partners, investors in the global cannabis industry.  MedMen is a cannabis retailer with operations across the U.S., including flagship stores in Los Angeles, Las Vega,s and New York.

________

The Green Organic Dutchman Holdings Ltd. (TGODF) (Market Cap: $702.479M; Share Price: $2.602) announced that it has secured a cannabis supply agreement with Alberta Gaming, Liquor & Cannabis.  By partnering in this agreement, TGODF plans to expand its Western Canadian footprint.  TGODF is a large Canadian producer of organic cannabis flowers and oils.

________

MariMed Inc. (MRMD) (Market Cap: $599.634M; Share Price: $2.82) reported 1st-quarter results ending March 31, 2019, indicating revenue growth and improved operating performance as compared to 2018.  Results are attributed to operational improvements under company management.  MariMed, Inc. offers a range of cannabis products with a separate division focused on industrial hemp-derived CBD products.

Legal Disclaimer:

This article was written by Regal Consulting, LLC (“Regal Consulting”).  Regal Consulting has agreed to a three-month term consulting agreement with THCT dated 2/14/18.  The agreement calls for 50,000 restricted shares of THCT per month. This agreement has been amended to $20,000 per month, and 55,000 shares per month and extended for twelve months ending 3/18/2020.  All payments were made directly by THC Therapeutics, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of.  Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice.  This article is based on public information and the opinions of Regal Consulting. THCT was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein.  Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.

http://www.regalconsultingllc.com/full legal disclaimer/

Full Legal Disclaimer Click Here.

Contact Information:

Company Name: ACR Communication LLC.

Contact Person: Media Manager

Email: info@microcapspeculators.com

Phone: 1-702-720-6310

Country: United States

THC Therapeutics (CE) (USOTC:THCT)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

THC Therapeutics (CE) (USOTC:THCT)
Historical Stock Chart
Von Nov 2023 bis Nov 2024